GEMAYEL GEORGES
SEC insider (Form 3/4/5 filer). CIK 0001256088. Director at Disc Medicine, Inc. (IRON) and 1 other issuer. 22 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in WATERTOWN, MA.
Companies GEMAYEL GEORGES has filed insider reports for
- Disc Medicine, Inc. (IRON): Director
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Director
GEMAYEL GEORGES
CIK: 0001256088
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 18, 2026IRON
Disc Medicine, Inc.
AwardDirectStock Option (Right to Buy)
6.2K shares- - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect8.8K shares at avg. $53.00$466K - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect7.9K shares at avg. $25.30$200K - Mar 5, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect10K shares at avg. $53.71$537K - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
DispositionDirectRestricted Stock Unit
4.5K shares- - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirect4.5K shares- - Feb 23, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect15K shares at avg. $12.98$195K - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Unit
3K shares- - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectDirector Stock Option (Right to Buy)
5K shares- - Sep 16, 2025IRON
Disc Medicine, Inc.
AwardDirectStock Option (Right to Buy)
1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  IRON Disc Medicine, Inc. | Award Stock Option (Right to Buy) | 6,212 | - | - | Direct |
| Mar 6, 2026 |  SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 8,787 | $53.00 | $465,711 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 7,905 | $25.30 | $199,997 | Direct |
| Mar 5, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 10,000 | $53.71 | $537,100 | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Disposition Restricted Stock Unit | 4,475 | - | - | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award | 4,475 | - | $0 | Direct |
| Feb 23, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 15,000 | $12.98 | $194,700 | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Restricted Stock Unit | 2,989 | - | - | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Director Stock Option (Right to Buy) | 4,977 | - | - | Direct |
| Sep 16, 2025 | IRON Disc Medicine, Inc. | Award Stock Option (Right to Buy) | 1,000 | - | - | Direct |
1-10 of 22 transactions